Research article
Additional food folate derived exclusively from natural sources improves folate status in young women with the MTHFR 677 CC or TT genotype

https://doi.org/10.1016/j.jnutbio.2005.11.009Get rights and content

Abstract

The effectiveness of additional food folate in improving folate status in humans is uncertain particularly in people with the common genetic variant (677 C→T) in the methylenetetrahydrofolate reductase (MTHFR) gene. To examine the effect of a doubling of food folate consumption on folate status response variables, women (n=32; 18–46 years) with the MTHFR 677 CC or TT genotype consumed either 400 (n=15; 7 CC and 8 TT) or 800 (n=17; 8 CC and 9 TT) μg/day of dietary folate equivalents (DFE) derived exclusively from naturally occurring food folate for 12 weeks. A repeated measures two-factor ANOVA was used to examine the effect of the dietary treatment, the MTHFR C677T genotype and their interactions on serum folate, RBC folate and plasma total homocysteine (tHcy) during the last 3 weeks of the study. Consumption of 800 μg DFE/day resulted in serum folate concentrations that were 67% (P=.005) higher than consumption of 400 μg DFE/day (18.6±2.9 vs. 31.0±2.7 nmol/L, respectively) and RBC folate concentrations that were 33% (P=.001) higher (1172±75 vs. 1559±70 nmol/L, respectively). Serum folate (P=.065) and RBC folate (P=.022) concentrations were lower and plasma tHcy was higher (P=.039) in women with the MTHFR 677 TT genotype relative to the CC genotype. However, no genotype by dietary treatment interaction was detected. These data suggest that a doubling of food folate intake will lead to marked improvements in folate status in women with the MTHFR 677 CC or TT genotype.

Introduction

Suboptimal folate status is associated with vascular disease, certain cancers, impaired cognition, pregnancy complications and fetal malformations including neural tube defects or NTDs [1], [2]. In an effort to increase folate consumption among women of childbearing age and reduce the incidence of NTD-affected pregnancies, the United States and a limited number of other countries (i.e., Canada and Chile) mandated folic acid fortification of staple food items [3]. Folic acid is the oxidized monoglutamate form of folate and is about twice as bioavailable as naturally occurring food folates [4], [5], most of which exist in the reduced form as a mixture of mono- and polyglutamates [6]. In the United States, folic acid fortification has resulted in substantial improvements in the folate status of women of childbearing age [7], [8] and has virtually eliminated folate deficiency in American adults [9]. However, most of the world's population is not exposed to widespread folic acid fortification and, therefore, must rely on supplemental folic acid or increased consumption of foods with a high content of natural folate to optimize their folate intake/status.

A valid concern of relying exclusively on increased consumption of folate-rich foods to optimize folate status is the efficacy of naturally occurring food folate. Studies providing about onefold additional food folate report percent changes ranging from +15% to 85% for serum folate, nonsignificant to +18% for RBC folate and nonsignificant to −16% for plasma total homocysteine (tHcy) [10], [11], [12], [13], [14], [15], [16]. The short-term nature (i.e., ≤5 weeks) of these studies and/or the lack of controlled folate intake may have contributed to the poor response and/or to the large amount of variability observed overall.

The question as to whether additional food folate is effective in improving folate status may be especially critical in people with genetic variations that alter folate requirements. A common polymorphism in methylenetetrahydrofolate reductase (MTHFR), a key regulatory gene in folate metabolism, occurs at nucleotide 677 and involves a cytosine-to-thymine transition [17]. People with the MTHFR 677 TT genotype have lower blood folate and higher plasma tHcy concentrations than those with the CC genotype [18], particularly under conditions of folate insufficiency, and are at greater risk for NTD-affected pregnancies and other pathologies [19], [20]. While folic acid administration is efficacious in persons with the MTHFR 677 TT genotype [21], [22], only limited data are available on the usefulness of additional food folate in improving their folate nutriture.

The objective of this study was to examine the effect of a doubling of food folate consumption on serum folate, RBC folate and plasma tHcy in women with the MTHFR 677 CC (n=15) or TT (n=17) genotype under conditions of controlled folate intakes.

Section snippets

Subjects

Healthy female subjects aged 18–46 years were recruited between January 2002 and April 2003 from the staff and student population at Cal Poly Pomona University as well as the surrounding community. The subjects were eligible for inclusion if the following criteria were fulfilled: no history of vascular, gastrointestinal, renal or hepatic disease; normal blood glucose and lipid concentrations; normal blood chemistry; MTHFR 677 CC or TT genotype; nonsmoker; not taking drugs known to interfere

Subject characteristics

The final study group was composed of 32 women with a median age of 22 years (range: 19–46 years) and a median body mass index (BMI) (kg/m2) of 23.0 (range: 19.1–36.0). The 400 μg DFE/day group consisted of 15 subjects: 7 with the MTHFR 677 CC genotype (1 African American, 3 Asians, 1 Caucasian and 2 Mexican Americans) and 8 with the MTHFR 677 TT genotype (1 Arabian, 2 Asians, 1 Caucasians and 4 Mexican Americans). The 800 μg DFE/day group consisted of 17 subjects: 8 with the MTHFR 677 CC

Discussion

This is the first long-term controlled folate feeding study to examine the effect of a doubling of food folate consumption on folate status in women with the MTHFR 677 CC or TT genotype. Because this study was conducted after folic acid fortification of staple food items, comparisons were made between the 400 and 800 μg DFE/day diet using data obtained during the final 3 weeks of folate treatment (Weeks 12–14) for serum folate, RBC folate and plasma tHcy. Changes from baseline (Week 0) or even

Acknowledgments

The authors wish to thank Dr. Lynn Bailey for her critical reading and suggestions to the manuscript. We are also indebted to the women whose participation made this study possible.

References (32)

Cited by (28)

  • Effect of the methylenetetrahydrofolate reductase (MTHFR 677C>T) polymorphism on plasma homocysteine concentrations in healthy children is influenced by consumption of folate-fortified foods

    2010, Nutrition
    Citation Excerpt :

    Information from intervention studies that have assessed the importance of the MTHFR genotype under conditions of controlled folate intake is conflicting. Hung et al. [43] showed in a study of 32 women that a doubling of food folate intake will lead to marked improvements in folate status regardless of the MTHFR polymorphism. Yet another intervention in women supported that the MTHFR 677C > T polymorphism affects negatively the folate and Hcy responses in subjects consuming low folate diets followed by repletion with the recommended dietary allowance [44].

  • Nutritional deficiencies and hyperhomocysteinemia

    2021, Nutritional Management and Metabolic Aspects of Hyperhomocysteinemia
View all citing articles on Scopus

Supported by the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service, grant number 2001-35200-10678, and funds from the California Agricultural Research Initiative.

View full text